These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 5699094)

  • 1. Prevention of ventricular fibrillation induced by coronary ligation.
    Kaumann AJ; Aramendía P
    J Pharmacol Exp Ther; 1968 Dec; 164(2):326-32. PubMed ID: 5699094
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 4. Cesium in the prevention of cardiac arrhythmias induced by coronary ligation.
    Prasad K; Simani AS; Dolan AM; Sterns LP; Callaghan JC
    Surg Forum; 1970; 21():166-7. PubMed ID: 5514720
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic mechanisms in the initiation of cardiac arrhythmias.
    Garvey HL
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):376-90. PubMed ID: 4391896
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R; Greeff K; Wagner J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of ventricular fibrillation thresholds after sympatholytic drugs in the dog.
    Wellens D; Wauters E
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):355-71. PubMed ID: 4403391
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of verapamil on baroreflex sensitivity and on cardiovascular variability.
    Gmitrov J; Andrejko S
    Wien Klin Wochenschr; 2000 Feb; 112(4):162-8. PubMed ID: 10726329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Actions of sparteine and sparteine derivatives on the heart and circulation].
    Raschack M
    Arzneimittelforschung; 1974 May; 24(5):753-9. PubMed ID: 4408029
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic prevention of fibrillation in acute ischemia of the heart and the dynamics of electrolytes].
    Popova NK; Ivashkevich EI
    Biull Eksp Biol Med; 1965 May; 59(5):64-7. PubMed ID: 5880812
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of iproveratril and nitroglycerin in the heart and coronary circulation of dogs.
    Ross G; Jorgensen C
    Am Heart J; 1968 Jul; 76(1):74-8. PubMed ID: 4968958
    [No Abstract]   [Full Text] [Related]  

  • 12. Verapamil in cardiology.
    Krikler D
    Eur J Cardiol; 1974 Aug; 2(1):3-10. PubMed ID: 4153535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Screening of substances with coronary vasodilator action].
    Lenke D
    Arzneimittelforschung; 1970 May; 20(5):655-67. PubMed ID: 5468054
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic properties of a new derivative of theophylline: bamifylline].
    Moret PR; Fournet PC; Boufas D
    Schweiz Med Wochenschr; 1970 Mar; 100(10):462-7. PubMed ID: 5423732
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of coronary vasodilators on coronary and systemic circulation. Experiments on the hearts of anesthetized dogs.
    Seta K
    Jpn Circ J; 1970 Jun; 34(6):499-511. PubMed ID: 5537669
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of physostigmine on ventricular fibrillation and myocardial glycogen in hypothermic dogs.
    Das PK; Sinha PS
    Br J Pharmacol; 1972 Mar; 44(3):391-6. PubMed ID: 5040657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
    Angus JA; Brazenor RM; Le Duc MA
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dependence of pharmacodynamically produced changes of the arteriovenous oxygen difference of the heart on the extracellular pH].
    Wolner E; Kraupp O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):298-309. PubMed ID: 4222747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.